Avidity Biosciences (RNA) Earnings Date, Estimates & Call Transcripts → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free RNA Stock Alerts $40.85 +0.31 (+0.76%) (As of 06/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 15) -$0.79 Beat By $0.02 Consensus EPS (May. 15) -$0.81 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RNA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Avidity Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.78)($0.78)($0.78)Q2 20241($0.80)($0.80)($0.80)Q3 20241($0.83)($0.83)($0.83)Q4 20241($0.86)($0.86)($0.86)FY 20244($3.27)($3.27)($3.27)RNA Earnings Date and InformationAvidity Biosciences last issued its quarterly earnings data on May 15th, 2024. The biotechnology company reported ($0.79) earnings per share for the quarter, beating analysts' consensus estimates of ($0.81) by $0.02. The company earned $3.54 million during the quarter, compared to the consensus estimate of $7.09 million. Avidity Biosciences has generated ($2.95) earnings per share over the last year (($2.95) diluted earnings per share). Earnings for Avidity Biosciences are expected to decrease in the coming year, from ($3.15) to ($3.28) per share. Avidity Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Avidity Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/15/2024-($0.81)($0.79)+$0.02($0.79)$7.09 million$3.54 million2/28/2024Q4 2023($0.54)($0.79)($0.25)($0.79)$32.08 million$2.19 million11/8/2023Q3 2023($0.76)($0.71)+$0.05($0.71)$2.09 million$2.82 million8/8/2023Q2 2023($0.84)($0.66)+$0.18($0.66)$2.09 million$2.32 million5/9/2023Q1 2023($0.90)($0.74)+$0.16($0.74)$2.08 million$2.23 million2/28/2023Q4 2022($0.84)($0.88)($0.04)($0.88)$2.39 million$2.77 millionBiden Nomination CANCELED? (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning.11/8/2022Q3 2022($0.97)($0.82)+$0.15($0.82)$2.39 million$2.48 million8/9/2022Q2 2022($0.74)($0.92)($0.18)($0.92)$2.29 million$2.18 million5/10/2022Q1 2022($0.94)($0.71)+$0.23($0.71)$1.50 million$1.80 million3/1/2022Q4 2021($0.73)($0.82)($0.09)($0.82)$2.20 million$1.85 million11/9/2021Q3 2021($0.68)($0.68)-($0.68)$1.50 million$2.16 million8/8/2021Q2 2021($0.71)($0.70)+$0.01($0.70)$1.50 million$2.61 million5/11/2021Q1 2021($0.56)($0.64)($0.08)($0.64)$1.50 million$2.70 million3/14/2021Q4($0.3430)($0.43)($0.0870)($0.43)-$2.14 million11/10/2020Q3 2020($0.37)($0.31)+$0.06($0.31)-$1.75 million8/10/2020Q2($0.24)($1.23)($0.99)($1.23)-$1.54 million Avidity Biosciences Earnings - Frequently Asked Questions When is Avidity Biosciences's earnings date? Avidity Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on RNA's earnings history. Did Avidity Biosciences beat their earnings estimates last quarter? In the previous quarter, Avidity Biosciences (NASDAQ:RNA) reported ($0.79) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.81) by $0.02. Learn more on analysts' earnings estimate vs. RNA's actual earnings. How much revenue does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded annual revenue of $9.56 million. How much profit does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded net income of -$212.22 million. RNA has generated -$2.95 earnings per share over the last four quarters. What is Avidity Biosciences's EPS forecast for next year? Avidity Biosciences's earnings are expected to decrease from ($3.15) per share to ($3.28) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ORIC Pharmaceuticals Earnings Results Nkarta Earnings Results Solid Biosciences Earnings Results United Therapeutics Earnings Results Viatris Earnings Results Dr. Reddy's Laboratories Earnings Results Insmed Earnings Results Catalent Earnings Results Elanco Animal Health Earnings Results Intra-Cellular Therapies Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: BlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings DropApple Stock All-Time Highs: Can AI Outweigh Earnings Jitters? This page (NASDAQ:RNA) was last updated on 6/30/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWhere AI is REALLY Going NextBuying Nvidia was a good idea – twenty years ago when I first recommended it (for up to 37,000% gains). But...InvestorPlace | SponsoredHistoric NVIDIA partnership could send this tiny AI stock soaring...After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's...Behind the Markets | SponsoredA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCatalyst Could Trigger 10,000% Crypto GainsAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Avidity Biosciences, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.